Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. META
6. SPY
7. ACN
8. NVDA
9. PRIM
10. PFE

Go back to Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54
(NASDAQ: BBIO) Delayed: 69.38 +0.46 (0.67%)
Previous Close $68.92    52 Week High $ 
Open $68.57    52 Week Low $ 
Day High $69.90    P/E N/A 
Day Low $68.03    EPS $ 
Volume 936,317